Maximum serum creatinine

Nausea/ vomiting Slight fever Initial serum creatinine (mg/dl) Maximum serum creatinine (mg/dl) Duration of ARF (days) Renal CT findings... 

The mean serum creatinine level on the first visit was 4.7 2.8mg/dl. The mean maximum serum creatinine level was 6.0 3.1 mg/dl (Fig. 49, Table 4). The prognosis... 

Fig. 49. Distribution of maximum serum creatinine levels in patients with ALPE., patients who required hemodialysis...

Blood pressure and serum creatinine (SCr) should be assessed prior to beginning cyclosporine therapy to obtain accurate baselines, and should be reassessed biweekly once therapy is started for at least the first 12 weeks of therapy (until values stabilize), and then closely monitored during therapy. If SCr increases to 30% above the patient s baseline, the cyclosporine dosage needs to be decreased and SCr rechecked in a month. If the SCr is still above 30% of the patient s baseline, cyclosporine should be discontinued and only resumed when the SCr returns to within 10% of the patient s baseline. Cyclosporine should also be discontinued for inadequate response after 3 months use at the maximum dose.10,36... 

Renal function impairment - 5 mg once daily in patients with Ccr of less than 30 mL/min/1.73 m (serum creatinine greater than 3 mg/dL). Dosage may be titrated upward until BP is controlled or to a maximum of 40 mg/day. 

Serum sodium less than 130 mEq/L or with serum creatinine greater than 1.6 mg/dL Initiate at 2.5 mg/day under close medical supervision. The dose may be increased to 2.5 mg twice daily, then 5 mg twice daily and higher as needed, usually at intervals of 4 days or more. The maximum daily dose is 40 mg. 

NSAIDs and oral corticosteroids may be continued. Onset of action generally occurs between 4 and 8 weeks. If insufficient benefit is seen and tolerability is good (including serum creatinine less than 30% above baseline), the dose may be increased by 0.5 to 0.75 mg/kg/day after 8 weeks and again after 12 weeks to a maximum of 4 mg/kg/day. If no benefit is seen by 16 weeks of therapy, discontinue. There is limited P.1164... 

The aim is to remove the fluid gradually with a maximum weight loss of 0.5 kg/day in the absence of peripheral oedema, or 1.0 kg/day if peripheral oedema is present. Too rapid a diuresis will result in intravascular fluid loss rather than the peripheral oedema. The diuretic should be stopped if the serum sodium falls below 120 mmol/L or if there is a rising serum creatinine. Urinary electrolytes should be monitored to ensure that the spironolactone therapy is effective. The aim is to reverse the sodium/potassium ratio in the urine so that more sodium than potassium is excreted. Most frequent side-effects of spironolactone are those related to its anti-androgenic activity, such as decreased libido, impotence and gynaecomastia in men and menstrual irregularities in women. Other side-effects include hyperkalaemia, uraemia, hyponatraemia and nausea. 

Transient renal tubular dysfunction has been reported in a patient with asthma requiring mechanical ventilation who received sevoflurane for 9 days (36). Soda hme was not used, and the cumulative dose was 298 MAC-hours. Serum and urinary inorganic fluoride concentrations reached maximum concentrations of 71 and 2047 pmoPl respectively. Markers of renal tubular injury were also greatly raised (urinary A-acetyl-beta-o-glucosaminidase and beta2-microglobulin). However, urine volume, creatinine clearance, and serum creatinine and urea concentrations were unaffected. 

Schwertner has isolated albumin-associated fluorescent ligands that have an emission maximum of 415 nm (S17). The fluorescent species is very water soluble and can be removed by charcoal (S16). A positive correlation was found between fluorescence and serum creatinine in patients maintained on conservative treatment (D15), but not in patients already on hemodialysis (S16). Interestingly, the serum of patients with acute renal failure does not emit this fluorescence, a fact that has been proposed as a differential criterion between acute and chronic renal failure (V2). Mabuchi et al. have used HPLC to demonstrate numerous endogenous fluorescent substances at excitation (Ex) 322 nm/emission (Em) 415 nm in chronic renal failure and concluded that some of these fluorescent peaks probably represented peptidic substances, but did not identify any of them (M7). 

A clinical study in 23 healthy subjects found that while taking ketoconazole 200 mg daily for 10 days, the maximum serum levels and AUC of a single 5-mg dose of sirolimus were increased 4.3-fold and 10.9-fold, respectively. In a study in 6 kidney transplant patients, ciclosporin was stopped because of toxicity or rejection episodes and sirolimus was started. They were given a lower than recommended dose of sirolimus (250 to 500 micrograms daily) but were also given ketoconazole 100 to 200 mg daily, adjusted to maintain sirolimus levels within the therapeutic range. The serum creatinine of the patients improved and reduced from 230 micromol/L to 194 micromol/L. ... 

Azotaemia develops progressively with an increase in creatinine and urea. These findings point to a drop in the glomerular filtration rate (GFR) and renal blood flow. The quotient of creatinine in the urine and plasma is high (>40). Likewise, the quotient of urea-N in the urine and plasma is elevated (> 8). There is a reduction in creatinine clearance within 24 hours to < 40 ml/min. The serum value of urea displays a disproportionate increase compared to creatinine (urea-N/creatinine ratio >20), since the tubular reabsorptive capacity with respect to urea depends on diuresis (maximum 2 ml/ min). In hepatorenal syndrome, the minimal urinary flow gives rise to a longer tubular period of contact with greater tubular reabsorption of urea. 

Renal concentrating abiUty is reduced in the elderly adult, so that creatinine clearance may decline by as much as 50% between the third and ninth decades. This decreased clearance is caused more by a decrease in urinary creatinine excretion as a result of decreased lean body mass than by altered renal function. The tubular maximum capacity for glucose is reduced. The plasma urea concentration rises with age, as does the urinary excretion of protein. The serum median IgG and IgM concentrations are reduced in the elderly although serum IgA concentrations in men increase shghtly in the elderly. 

---